title: Development of five new melanoma low passage cell lines representing the clinical and genetic profile of their tumors of origin.
authors.forename: Eleazar Vega-Saenz
authors.initials: EV
authors.lastname: de Miera
authors.forename: Erica B
authors.initials: EB
authors.lastname: Friedman
authors.forename: Holly S
authors.initials: HS
authors.lastname: Greenwald
authors.forename: Mary A
authors.initials: MA
authors.lastname: Perle
authors.forename: Iman
authors.initials: I
authors.lastname: Osman
mesh_terms: D045744:Cell Line, Tumor; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D019942:Genes, p16; D006801:Humans; D008545:Melanoma / Q000145:classification / Q000235:genetics / Q000473:pathology*; D020125:Mutation, Missense / Q000502:physiology; D009382:Neoplasms, Unknown Primary / Q000145:classification / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D020641:Polymorphism, Single Nucleotide; D061251:Primary Cell Culture / Q000379:methods*; D011379:Prognosis; D048493:Proto-Oncogene Proteins B-raf / Q000235:genetics; D012326:RNA Splicing / Q000235:genetics; D012878:Skin Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology*
chemical_list: C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf